About Spinnaker Biosciences
Spinnaker Biosciences is a private company based in Solana Beach, California. It has reported $2,566,780 raised in three offerings on Form D since December 2010. Its chief executive is Malcolm Finlayson.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 26, 2024 | Dec 9, 2024 | $666,780of $1.2M target | 1 | $666K | EquityRule 506(b) | Form D ↗ |
| Oct 3, 2014 | May 28, 2015 | $900,000of $3.0M target | 2 | $450K | EquityRule 506(b) | Form D ↗ |
| Dec 1, 2010 | Dec 14, 2010 | $1,000,000of $3.0M target | 1 | $1.0M | Equity06 | Form D ↗ |
| Total, three offerings | $2,566,780 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Spinnaker Biosciences's Form D filed Dec 9, 2024.
MF
Malcolm Finlayson
Chief Executive Officer and director
MS
Michael Sailor
Director
WF
William Freeman
Director
Earlier filings also listed Virgil Thompson (president and ceo, director, last listed May 2015).